Broncus Technologies is a medical technology company focused on developing and commercializing innovative solutions for lung diseases. With LungPoint™, physicians plan bronchoscopic procedures and navigate to locations in the lungs accurately and quickly. Its line of Yield™ catheters are used to obtain tissue samples and detect blood vessels. Its patented treatment method, Airway Bypass using Exhale® Drug-Eluting Stents, is being investigated to determine if it can provide the first minimally-invasive treatment option for homogeneous, or diffuse, emphysema, the form of the disease experienced by the majority of emphysema patients.

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

Asthmatx, Inc., a medical device company, focuses on developing and commercializing a therapeutic treatment for asthma in the United States. The company has developed a technology that is designed to deliver controlled thermal energy to the airways of adult patients to reduce the mass of airway smooth muscle in a procedure called Bronchial Thermoplasty. Asthmatx offers an interventional medical device, called the Alair System, for the bronchoscopic treatment of patients with moderate to severe asthma. Asthmatx was founded in 2003 and is headquartered in Mountain View, California. As of October 26, 2010, Asthmatx operates as a wholly-owned subsidiary of [Boston Scientific](/organization/boston-scientific).

Broncus Technologies is a medical technology company focused on developing minimally-invasive medical devices for emphysema and other lung diseases. Broncus is investigating the Exhale emphysema product line to perform our patented treatment method called Airway Bypass. Airway Bypass could be the first minimally-invasive procedure for the treatment of homogeneous, or diffuse, emphysema, which constitutes the majority of the emphysema patient population. Broncus is currently enrolling patients worldwide in our pivotal EASE Trial investigating a treatment of severe homogeneous emphysema. Broncus is located in Mountain View, CA (San Francisco Bay area). Broncus International is located in Nyon, Switzerland.

Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases. Nuvaira is currently working on a novel catheter-based system that has the potential to improve lung function, exercise capacity, and quality of life for patients with chronic obstructive pulmonary disease. It was founded in 2008 and headquartered in Minneapolis, Minnesota.

Gyrus ACMI, Inc. (doing business as Olympus Surgical Technologies America), part of Olympus Corp., is an American company located in Southborough, MA, that manufactures and sells precision machineries & instruments.

Spiration, Inc., doing business as Olympus Respiratory America, develops medical devices for the treatment of air leaks and lung diseases. The company was founded in 1999 and is based in Redmond, Washington. As of 2010, Spiration, Inc. operates as a subsidiary of Olympus America Inc.

Part of Medtronic Plc, Covidien Pte Ltd. is a Singaporean company located in Singapore that manufactures and supplies medical equipment.

Manufactures healthcare equipment

Siemens Medical Solutions USA, Inc. provides medical products and solutions. It offers imaging systems, therapy equipment, and hearing instruments for diagnosis, treatments, and patient monitoring. The firm services include imaging and therapy, customer resources and logins, healthcare financing solutions and laboratory diagnostics services. The company was founded in 1896 and is headquartered in Malvern, PA.

Free Flow Medical develops a next-generation medical device to treat patients with emphysema, an advanced form of chronic obstructive disease (COPD) that severely limits the quality of life, presents the patient with ongoing severe breathlessness and eventual mortality. The company's technology includes a minimally-invasive tool that helps prevent shortness of breath, enabling doctors to help treat patients suffering from emphysema. It incubates inside the Spin-Off Factory and is the first company to be spun out.

Pulmonx is the global leader in interventional procedures for the treatment of COPD. It develops and markets non-surgical technologies for the assessment and treatment of patients with severe emphysema, a progressive and life-threatening form of COPD. The Pulmonx solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The technology is supported by a compelling body of clinical evidence including over 100 published scientific articles regarding the clinical benefits of Zephyr Valves. FDA granted the Zephyr Valve a ‘breakthrough device’ designation, and in June 2018 Pulmonx received FDA pre-market approval to commercialize our Zephyr Valve. The Zephyr Valve is now commercially available and physicians in more than 25 countries around the world routinely use the Zephyr Valves to improve the lives of patients with severe emphysema, with over 76,000 valves used to treat more than 19,000 patients worldwide to date.

Oventus is an Australian-based medical device company established in 2012. In 2013, Oventus collaborated with Australia’s national science agency – the Commonwealth Scientific and Industrial Research Organization (CSIRO) – to develop an innovative, customized mouthguard that is changing the lives of people who snore or have obstructive sleep apnea. Bringing the technology to the U.S, Oventus aims to become a world leader in sleep-disordered breathing treatment by commercializing a suite of revolutionary oral appliances that provide increased airflow.

EKOS Corporation pioneered the development and the clinical application of ultrasound accelerated thrombolysis, introducing its first system for the treatment of vascular thrombosis in 2005. Today, interventional radiologists, cardiologists and vascular surgeons at leading institutions around the world use the EKOS EkoSonic Endovascular System to provide faster, safer and more complete dissolution of thrombus.

Horizon, Inc. designs and constructs commercial HVAC and plumbing systems. It offers plumbing systems for multi-family, student housing, military privatization, and commercial and residential construction sectors. The company is headquartered in Ridgeland, SC.

Part of Colgate-Palmolive Co., The Kendall Co. is an American company located in Exeter, NH, that makes disposable medical supplies and other specialty products.

Fuwei Perception (Hefei) Technology Co., Ltd., established on 2019-07-17, Business scope includes integrated circuit research and development,design;Sensitive components and sensors,chip,sensor,Electronic Component,Electronic module,household appliances,vehicle electronics,Industrial electrical,Explosion-proof electrical equipment,new material,Flammable and toxic gas detection alarm,Class I,Class II,Class III medical device,Design of Medical Materials,research and development,Production(limited branch),Sales;Clinical Laboratory Services;Medical Research and Experimental Development;biotechnology development,Biomedical technology promotion service;Biomedical Technology Research,consult;Information Technology,computer technology,Internet technology,communication technology,Ecotechnology,Technical consulting in the field of transportation and energy technology,Technical Services,technology development,technology transfer,Technology Promotion;computer software development,Sales(In addition to special products for computer information system security);Chemical Products,building materials,Electronic product testing service;ecology,Environmental Protection Monitoring;Engineering and Technology Research and Experimental Development;Chemical Engineering Research Services;Entrepreneurial Consulting Services;Metering Technology Consulting Services;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that are restricted by the state to be operated by enterprises or prohibited from import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Mitsubishi Electric Corp. engages in the manufacture, development, and sale of electric and electronic equipment. It operates in the following business segments: Energy and Electric Systems, Industrial Automation Systems, Information and Communication Systems, Electronic Devices, Home Appliances, and Others. The Energy and Electric Systems segment offers power and transportation systems, elevators, escalators, and supervisory control systems. The Industrial Automation Systems segment covers industrial automation products and systems, measurement and control systems, automotive and electronic products, and car multimedia systems. The Information and Communication Systems segment includes wireless, closed circuit television, space, and satellite communication systems, antennas, radar devices, and information communications network systems. The Electronic Devices segment provides power, high frequency, and optical devices; and liquid crystal displays. The Home Appliances segment covers air-conditioning and photovoltaic power generation systems, televisions, recorders, and players. The Others segment comprises of material procurement, logistics, real estate, advertising, and financial services. The company was founded on January 15, 1921 and is headquartered in Tokyo, Japan.